We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Register Free
Advertise with Us
Latest Issue
Latest Issue
PURITAN MEDICAL

Download Mobile App




Events

more events
ATTENTION: Due to the CORONAVIRUS EPIDEMIC, certain events are being rescheduled for a later date or altogether cancelled. Please check with the event organizer or website prior to planning for any forthcoming event.
14 Apr 2020 - 17 Apr 2020
KoreaLab 2020
16 Apr 2020 - 17 Apr 2020
India Lab Expo & Analytica Anacon India
06 May 2020 - 10 May 2020
29th Annual Scientific and Clinical Congress of the American Association of Clinical Endocrinologists (AACE).

Pathology

Image: The cobas Epidermal Growth Factor Receptor (EGFR) gene Mutation Test v2 (Photo courtesy of Roche).

Early Prediction of Resistance to Tyrosine Kinase Inhibitors Reported

 Epidermal growth factor receptor (EGFR) gene mutations that confer sensitivity to tyrosine kinase inhibitors (TKI) in non-small cell lung carcinomas paved the way for a precision medicine approach in this neoplastic form. More...
31 Mar 2020
Image: Schematic diagram of a urine score for noninvasive accurate diagnosis and prediction of kidney transplant rejection study (Photo courtesy of the University of California, San Francisco).

Urine-Based Kidney Transplantation Rejection Risk Assay Launched

 For kidney transplant recipients, prompt and accurate detection of transplant rejection is vital for timely intervention. Unfortunately, the gold standard for diagnosis of rejection is kidney biopsy, an invasive procedure. More...
30 Mar 2020
Image: Histopathology of cancerous breast tissue, the tumor cells have proliferated in a close pattern without tubular formation. This tumor represented moderately differentiated ductal carcinoma (Photo courtesy of The Japanese Society of Pathology).

Genetic Testing Benefits Postmenopausal Women with Breast Cancer

 Germline genetic testing for pathogenic variants (PVs) in cancer susceptibility genes after breast cancer diagnosis may inform cancer treatment, prevention, and testing of relatives. Postmenopausal women with breast cancer had a threefold higher prevalence of pathogenic variants in breast cancer-associated genes than their cancer-free counterparts. More...
26 Mar 2020
Image: Multitarget Stool DNA Screening has a high positive predictive value for colorectal neoplasia regardless of exposure to previous colonoscopy (Photo courtesy of Madeline Morr).

Multitarget Stool DNA Predicts Colorectal Neoplasia

 Most colorectal cancers are due to old age and lifestyle factors, with only a small number of cases due to underlying genetic disorders. Screening is effective for preventing and decreasing deaths from colorectal cancer. More...
25 Mar 2020
Image: Circulating tumor DNA (ctDNA) assays can be used for the sensitive detection of minimal residual disease in patients treated for early-stage breast cancer (Photo courtesy of Natera).

Liquid Biopsy Assays Target Mutations and Improves Recurrence Prediction

 The concept of creating bespoke or personalized mutation panels to use for cancer recurrence detection and residual disease monitoring is not new at this point. Scientists began piloting these methods several years ago, initially tracking single mutations and then collections of alterations derived from tumor sequencing data. More...
25 Mar 2020
Image: The fully automated Idylla EGFR Mutation Test covers 51 mutations in exons 18–21 in a single cartridge using only one FFPE tissue section from metastatic non-small cell lung cancer (NSCLC) showing a high concordance of >95% compared with reference methods (Photo courtesy of Biocartis).

EGFR Mutation Assay Cartridges Evaluated

 Lung cancer remains the leading cause of cancer deaths. The management of lung cancer has been aided by the better understanding of molecular mechanisms involved in its initiation and progression and increased usage of molecular testing. More...
24 Mar 2020
Image: The XE-5000 Hematology Analyzer is a high volume analyzer that offers unique clinical parameters to aid in better patient care (Photo courtesy of Sysmex Corporation).

Prognostic Values of Platelet Parameters in Gynecological Tumors Patients

 Gynecologic cancers often involve the uterus, ovaries, cervix, vulva, vagina, fallopian tubes, or the peritoneum. The most common gynecologic cancer in the USA is endometrial cancer, followed by ovarian cancer. Many gynecologic cancers manifest as pelvic masses. More...
24 Mar 2020

In Other News



The Pathology channel details advances in the field of Surgical Pathology and all its subspecialties, including Cytopathology and its subspecialties.

LabMedica

About Us
Advertising Info
Subscription
Client Login
Privacy Policy
Cookie Policy
Journal Info
Contact Us

Channels

Clinical Chemistry
Molecular Diagnostics
Hematology
Immunology
Microbiology
Pathology
Lab Tech.
BioResearch
Industry News
Events

Features

Events Product Showcase LinkXpress Whitepapers archive Video Library

Partner Sites

TradeMed.comHospiMedica.com Globetech.net
Copyright © 2000-2020 Globetech Media. All rights reserved.
MOBILE | FULL SITE